Detalles de la búsqueda
1.
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
N Engl J Med
; 380(12): 1116-1127, 2019 03 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30779529
2.
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France.
BMC Cancer
; 15: 222, 2015 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-25884302
3.
A pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multicenter, retrospective study.
Anticancer Drugs
; 25(8): 970-5, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24849707
4.
Open-label uncontrolled pilot study to evaluate complementary therapy with Ruta graveolens 9c in patients with advanced cancer.
Homeopathy
; 103(4): 232-8, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25439039
5.
Clinical results of the EVESOR trial, a multiparameter phase I trial of everolimus and sorafenib combination in solid tumors.
Cancer Chemother Pharmacol
; 91(5): 361-373, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36840749
6.
A PK-PD model linking biomarker dynamics to progression-free survival in patients treated with everolimus and sorafenib combination therapy, EVESOR phase I trial.
Cancer Chemother Pharmacol
; 91(5): 413-425, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37010549
7.
Characterization and Management of Treatment-emergent Hepatic Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving First-line Pembrolizumab plus Axitinib. Results from the KEYNOTE-426 Trial.
Eur Urol Oncol
; 5(2): 225-234, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34244116
8.
Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs.
BMC Cancer
; 11: 478, 2011 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-22067636
9.
Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer.
Cancers (Basel)
; 13(23)2021 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34885125
10.
Improved Androgen Receptor Splice Variant 7 Detection Using a Highly Sensitive Assay to Predict Resistance to Abiraterone or Enzalutamide in Metastatic Prostate Cancer Patients.
Eur Urol Oncol
; 4(4): 609-617, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31676281
11.
First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?
Cancers (Basel)
; 13(21)2021 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34771710
12.
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study.
Clin Genitourin Cancer
; 19(4): e216-e222, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33753043
13.
Neuroendocrine Carcinoma of the Urinary Bladder: A Large, Retrospective Study From the French Genito-Urinary Tumor Group.
Clin Genitourin Cancer
; 18(4): 295-303.e3, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31882335
14.
Denosumab Toxicity When Combined With Anti-angiogenic Therapies on Patients With Metastatic Renal Cell Carcinoma: A GETUG Study.
Clin Genitourin Cancer
; 17(1): e38-e43, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30279115
15.
Lingual metastasis as an initial presentation of renal cell carcinoma: a case report.
J Med Case Rep
; 11(1): 314, 2017 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29110685
16.
Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship.
Cancer Res
; 64(13): 4664-9, 2004 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15231679
17.
Second treatment with rituximab in B-cell non-Hodgkin's lymphoma: efficacy and toxicity on 41 patients treated at CHU-Lyon Sud.
Hematol J
; 5(6): 467-71, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15570286
18.
Maintenance therapy with a monthly injection of alemtuzumab prolongs response duration in patients with refractory B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL).
Leuk Lymphoma
; 45(4): 711-4, 2004 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15160944
19.
Pure Seminoma and Concurrent Aggressive Lymphoma: Case Report of a Patient With Persistent Müllerian Duct Syndrome.
Clin Genitourin Cancer
; 17(2): e369-e371, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30587405
20.
Curative treatment can be an option for patients with metastatic squamous cell cancer of the head and neck.
Drug Des Devel Ther
; 8: 2549-53, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25548517